CMS certification 380061
Providence Portland Medical Center
4805 NE Glisan Street, Portland, OR 97213
Providence Portland Medical Center has a CMS overall rating of 4 out of 5 stars. 77% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 25 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 3 and worse on none. Emergency patients spend a median of 3 h 35 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 443 completed surveys, 20% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as very high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | OR | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 371 visits sampled · US median for EDs of the same volume: 3 h 21 min | 3 h 35 min | 2 h 36 min | 2 h 42 min |
| Median time for psychiatric and mental health patients Lower is better · 36 visits sampled | 4 h 44 min | 3 h 42 min | 4 h 17 min |
| Left before being seen Lower is better · 62,367 patients | 4% | 3% | 2% |
| Stroke symptoms: brain scan read within 45 minutes Higher is better · 19 patients | 74% | 68% | 69% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 145 patients | 57% | 60% | 65% |
How Providence Portland Medical Center compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| Providence Portland Medical CenterThis hospital | 4/5 | 77% | 3 h 35 min | 3 better |
| Adventist Health PortlandSame city | 4/5 | 71% | 3 h 25 min | 3 better |
| Legacy Good Samaritan Medical CenterSame city | 4/5 | 74% | 3 h 3 min | 2 better |
| Providence St Vincent Medical CenterSame city | 4/5 | 79% | 3 h 50 min | 5 better 2 worse |
| Legacy Emanuel Medical CenterSame city | 3/5 | 74% | 2 h 50 min | 1 better 3 worse |
| Ohsu Hospital and ClinicsSame city | 3/5 | 76% | 3 h 44 min | 3 better 2 worse |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict. All hospitals in Portland.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 4,878 cases | Too few cases | 3.2% | 3.9% |
| Heart attack 147 cases | Too few cases | 11.5% | 11.9% |
| Heart failure 313 cases | Too few cases | 11.1% | 11.1% |
| Pneumonia 211 cases | Too few cases | 14.5% | 15.2% |
| Stroke 520 cases | Too few cases | 10.4% | 11.9% |
| COPD 71 cases | Too few cases | 8.8% | 8.6% |
1 more measure had too few cases here to report.
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | No different | 0.92 likely 0.65 – 1.18 | 1 |
| After hip or knee replacement 105 cases | Too few cases | 4.5% | 4.1% |
| Deaths after a serious but treatable surgical complication 108 cases | No different | 154.26 per 1,000 likely 111.52 per 1,000 – 197 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 5,053 cases | No different | 0.4 per 1,000 likely 0 per 1,000 – 0.97 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 5,800 cases | No different | 0.15 per 1,000 likely 0 per 1,000 – 0.35 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 6,223 cases | No different | 0.25 per 1,000 likely 0.05 per 1,000 – 0.44 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 1,966 cases | No different | 2.13 per 1,000 likely 0.81 per 1,000 – 3.45 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 1,168 cases | No different | 1.73 per 1,000 likely 0.32 per 1,000 – 3.14 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 945 cases | No different | 6.68 per 1,000 likely 1.32 per 1,000 – 12.05 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 2,035 cases | No different | 3.49 per 1,000 likely 1.71 per 1,000 – 5.28 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 1,086 cases | No different | 7.18 per 1,000 likely 4.33 per 1,000 – 10.03 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 710 cases | No different | 1.68 per 1,000 likely 0.32 per 1,000 – 3.05 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 1,774 cases | No different | 1.23 per 1,000 likely 0.42 per 1,000 – 2.04 per 1,000 | 1.06 per 1,000 |
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | Better | 0.47 likely 0.21 – 0.93 | 1 |
| Urinary tract infections from catheters (CAUTI) | No different | 0.91 likely 0.48 – 1.57 | 1 |
| Surgical site infections after colon surgery | No different | 0.76 likely 0.35 – 1.44 | 1 |
| Surgical site infections after abdominal hysterectomy | No different | 0.49 likely 0.03 – 2.43 | 1 |
| MRSA bloodstream infections | No different | 0.92 likely 0.43 – 1.75 | 1 |
| C. diff intestinal infections | Better | 0.32 likely 0.19 – 0.5 | 1 |
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 342 cases | Too few cases | 15.7% | 14.4% |
| Readmitted after heart failure 967 cases | Too few cases | 22% | 21.3% |
| Readmitted after pneumonia 596 cases | Too few cases | 17.4% | 17.3% |
| Readmitted after COPD 267 cases | Too few cases | 21.5% | 20% |
| Readmitted after hip or knee replacement 122 cases | Too few cases | 5.8% | 5.8% |
| Days back in hospital after a heart attack 160 cases | Too few cases | -11.8 days per 100 | — |
| Days back in hospital after heart failure 342 cases | Too few cases | 6.8 days per 100 | — |
| Days back in hospital after pneumonia 212 cases | Too few cases | -18.7 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 374 cases | No different | 14.1 per 1,000 likely 10.7 per 1,000 – 19.1 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 401 cases | No different | 9.4 per 100 likely 7.4 per 100 – 11.9 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 401 cases | Better | 3.3 per 100 likely 2.4 per 100 – 4.7 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 461 cases | No different | 1.1 likely 0.8 – 1.4 | — |
2 more measures had too few cases here to report.
Clinicians registered at this address
400 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Internal Medicine | 55 |
| Hospitalist | 37 |
| Physical Therapist | 24 |
| Emergency Medicine | 21 |
| Dietitian, Registered | 18 |
| Family | 16 |
| Surgery | 16 |
| Occupational Therapist | 14 |
| Nurse Anesthetist, Certified Registered | 10 |
| Radiation Oncology | 10 |
| Registered Nurse | 9 |
| Speech-Language Pathologist | 9 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $5.7M
- 2020 $7.1M
- 2021 $8M
- 2022 $10.5M
- 2023 $14.9M
- 2024 $11.9M
- 2025 $10.1M
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Space rental and facility fees | $48,850 | 21 |
| Medical devices and supplies on long-term loan | $35,967 | 20 |
| Speaking, teaching and other services | $12,995 | 5 |
| Honoraria | $279 | 1 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Pfizer INC. | $5.6M | 117 |
| Merck Sharp & Dohme LLC | $1.1M | 19 |
| AstraZeneca Pharmaceuticals LP | $711,323 | 13 |
| Janssen Research & Development, LLC | $521,188 | 52 |
| Eli Lilly and Company | $321,664 | 5 |
| Takeda Pharmaceuticals U.S.A., Inc. | $283,561 | 33 |
| Medtronic, Inc. | $201,759 | 19 |
| E.R. Squibb & Sons, L.L.C. | $154,395 | 14 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| ENCORAFENIBBINIMETINIB WITH OR WITHOUT NIVOLUMAB FOR PATIENTS WITH METASTATIC BRAF V600 MUTANT THYROID CANCER PFIZER INC. | $3.9M |
| TALAPRO3 A PHASE 3 RANDOMIZED DOUBLEBLIND STUDY OF TALAZOPARIB WITH ENZALUTAMIDE VERSUS PLACEBO WITH ENZALUTAMIDE IN MEN WITH DDR GENE MUTATED METAST… PFIZER INC. | $729,660 |
| Study of patients with incurable solid tumors undergoing T-cell receptor gene therapy targeting oncogenic driver mutations (neoantigens) AstraZeneca Pharmaceuticals LP | $523,633 |
| An Open-label, Randomized Phase 3 Study of MK-2870 as a Single Agent and in Combination with Pembrolizumab Versus Treatment of Physician s Choice in … Merck Sharp & Dohme LLC | $379,481 |
| A Phase 1 First inhuman Open Label Dose Escalation Study of JNJ61186372 a Human Bispecific EGFR and cMet Antibody in Subjects with Advanced Non Small… Janssen Research & Development, LLC | $317,977 |
| AN OPENLABEL MULTICENTER RANDOMIZED PHASE 3 STUDY OF FIRSTLINE ENCORAFENIB PLUS CETUXIMAB WITH OR WITHOUT CHEMOTHERAPY VERSUS STANDARD OF CARE THERAP… PFIZER INC. | $288,441 |
| AN OPEN-LABEL, DOSE ESCALATION, PHASE 1 STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF TAK-676 AS A SINGLE AGE… Takeda Pharmaceuticals U.S.A., Inc. · NCT04420884 | $247,378 |
| A PHASE 1AB OPENLABEL MASTER STUDY OF PF07799544 AS A SINGLEAGENT AND IN COMBINATION WITH OTHER TARGETED AGENTS IN PARTICIPANTS WITH ADVANCED SOLID T… PFIZER INC. | $242,424 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Providence Portland Medical Center
Is Providence Portland Medical Center a good hospital?
Providence Portland Medical Center has a CMS overall rating of 4 out of 5 stars. Of the 25 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 3 and worse on none. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend Providence Portland Medical Center?
77% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 443 completed HCAHPS surveys.
How long is the wait in the Providence Portland Medical Center emergency room?
Emergency patients spend a median of 3 h 35 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with very high patient volume, like this one, the median is 3 h 21 min. 4% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does Providence Portland Medical Center receive money from drug and device companies?
Drug and device makers reported $10.1M in payments to Providence Portland Medical Center for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.